$61.65
-0.75-1.21%
Last update: Oct 1, 2:00 PM
$62.40
N/A
Bristol-Myers Squibb Co
BMYNYSE
Bristol-Myers Squibb (BMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bristol-Myers Squibb (BMY) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $6.75 - $7, compared to a consensus EPS estimate of $6.31. Bristol-Myers Squibb also guided revenue in the range of $49B - $50B for the period.
Compared to prior guidance, Bristol-Myers Squibb raised its EPS outlook from a previous range of $6.05 - $6.35. On the revenue side, the company raised its revenue forecast from a prior range of $46B - $47.5B.
Bristol-Myers Squibb has issued 16 guidance updates between October 25, 2022 and July 30, 2026. During this period, the company raised its outlook 6 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.61 | $1.43 | $1.19 | $1.51 |
| Actual | $2.04 | $1.58 | $1.26 | $1.63 |
| Surprise | +26.7% | +10.5% | +5.88% | +7.95% |
| Revenue | ||||
| Estimate | $11.70B | $10.92B | $12.27B | $11.81B |
| Actual | $12.97B | $11.49B | $12.50B | $12.22B |
| Surprise | +10.9% | +5.23% | +1.93% | +3.47% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.72 | $1.61 | $1.44 | $1.71 |
| Revenue | ||||
| Consensus | $12.64B | $12.71B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $2.04 | $1.61 | 26.7 % |
| Q1 | Apr 30, 2026 | $1.58 | $1.43 | 10.5 % |
| Q4 | Feb 5, 2026 | $1.26 | $1.19 | 5.88 % |
| Q3 | Oct 30, 2025 | $1.63 | $1.51 | 7.95 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 30, 2026 | $12.97B | $11.70B | 10.9 % |
| Q1 | Apr 30, 2026 | $11.49B | $10.92B | 5.23 % |
| Q4 | Feb 5, 2026 | $12.50B | $12.27B | 1.93 % |
| Q3 | Oct 30, 2025 | $12.22B | $11.81B | 3.47 % |
